Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)

NCT00728923

Obsessive Compulsive Disorder

COMPLETED PHASE2

Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD

NCT01695291

Obsessive Compulsive Disorder

COMPLETED PHASE2

Memantine for Refractory OCD Patients

NCT05015595

Obsessive-Compulsive Disorder

UNKNOWN PHASE3

Treatment of Obsessive-Compulsive Disorder (OCD) in Children

NCT00000384

Obsessive-Compulsive Disorder

COMPLETED PHASE3

Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

NCT00352768

Obsessive Compulsive Disorder

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive Compulsive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Minocycline

Capsules

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets DSM-IV criteria for Obsessive Compulsive Disorder.
* CY-BOCS score of greater or equal to 16 at screening.
* NIMH Global OC Scale score of 7 or higher at screening.

Exclusion Criteria

* Patients planning to commence cognitive behaviour therapy during the period of the study or those who have begun cognitive behaviour therapy within 8 weeks prior to enrolment.
* Autistic Disorder or Pervasive Developmental Disorder.
* Moderate or severe mental retardation.
* Severe renal insufficiency.

Minimum Eligible Age

12 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No